91¿´Æ¬

The Lymphoma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat lymphoma, a type of cancer that affects the lymphatic system. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is the most common form of treatment for lymphoma, and involves the use of drugs to kill cancer cells. Targeted therapy is a newer form of treatment that uses drugs to target specific cancer cells, while immunotherapy uses drugs to stimulate the body's own immune system to fight the cancer. The Lymphoma Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more